ABELIAN THERAPEUTICS
Abelian Therapeutics is a biotechnology company which engages in harnessing factors in brain disease.
ABELIAN THERAPEUTICS
Industry:
Biotechnology Health Diagnostics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
617 338-2072
Total Funding:
0
Investors List
F-Prime Capital
F-Prime Capital investment in Seed Round - Abelian Therapeutics
More informations about "Abelian Therapeutics" on Search Engine
Neumora launches with $500 million to develop drugs …
Oct 7, 2021 Neumora has also acquired the early-stage startup Abelian Therapeutics, which was studying the role of glial cells in brain disease. Williams says Neumora has also been developing its own compounds …See details»
Armed with half a billion dollars, a startup aims to change how …
Oct 7, 2021 BlackThorn has since become a building block for Neumora, which acquired the the company along with private biotechs Abelian Therapeutics and Alairion and a …See details»
Brain-Disorder Startups Are Becoming the Next Megabiotechs
Oct 14, 2021 It combined BlackThorn and three other startups — Alairion, Syllable Life Sciences, Abelian Therapeutics — to create Neumora. It is the latest example of a …See details»
Abelian Therapeutics - Products, Competitors, Financials, …
Overview & Products. Financials. Founded Year. 2017. Stage. Seed VC | Alive. About Abelian Therapeutics. Abelian Therapeutics is a biotechnology company. It develops …See details»
Abelian Therapeutics | CipherBio
Abelian Therapeutics, Inc. operates as a biotechnology company, which engages in harnessing and investigating glia factors in brain disease. Stage: Public. Total Funds …See details»
Corporate Social Responsibility - Abelian
Oct 9, 2020 Abelian is incredibly grateful to partner with St. Jude Children’s Research Hospital in its mission to help discover cures for childhood cancers. We are inspired by …See details»
Abelian Therapeutics | CipherBio
Explore Abelian Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Abelian Therapeutics | VentureRadar
We are a preclinical stage biopharmaceutical company that leverages our expertise in the microbiome, translational research, and early stage technology commercialization to …See details»
Portfolio • F-Prime Capital
Abelian Therapeutics. Nascent biotech company harnessing emerging science on the importance of Glia in brain disease. Abelian Therapeutics was acquired in September …See details»
Meet Neumora, Arch's $500M, Amgen-partnered play for the …
Oct 7, 2021 Having quietly put the startup together over the past 18 months, Thursday Arch unveiled Neumora Therapeutics—a biotech that starts life with $500 million, a …See details»
Abelian Therapeutics Stock Price, Funding, Valuation, Revenue ...
Jan 1, 2017 About Us. Abelian Therapeutics. Unclaimed. Overview & Products. Financials. Investors Count. 1. Funding, Valuation & Revenue. 1 Fundings. Abelian …See details»
Abelian Therapeutics - EarlyBirds Open Innovation Ecosystem
Abelian Therapeutics on EarlyBirds Open Innovation Ecosystem. Abelian Therapeutics on EarlyBirds Open Innovation Ecosystem. Search 5M+ Innovators Transform your …See details»
ABELIAN THERAPEUTICS, INC. :: Massachusetts (US)
001307141. Status. Inactive. Incorporation Date. Please log in to see this data. Dissolution Date. Please log in to see this data. Company Type. Foreign Corporation. Jurisdiction. …See details»
Seed Round - Abelian Therapeutics - 2017-01-01 - Crunchbase
Organization Name . Abelian Therapeutics . Announced Date Jan 1, 2017; Funding Type Seed; Funding Stage Seed; Investors ...See details»
Healthcare Archives • F-Prime Capital
Abelian Therapeutics. Nascent biotech company harnessing emerging science on the importance of Glia in brain disease. Abelian Therapeutics was acquired in September …See details»
About Us - Broadview Ventures
Broadview Ventures is a mission-driven investment organization. Broadview's primary investment goal is to improve human health in the areas of cardiovascular disease and …See details»
@AbelianPartners | Twitter
The latest tweets from @AbelianPartnersSee details»
Weekly Report - March 31, 2021 - Abelian Partners
Mar 31, 2021 Home. Market Updates. Weekly Report – March 31, 2021. Download PDF. Highlight of the Week. Margin Call at Hedge Funds Hits Banks, Prompts Contagion …See details»
Britain refuses to sign global vaccine treaty that would force it to ...
May 8, 2024 This would include therapeutics, PPE and vaccines. The WHO document states the UN-run agency would get “real-time access” to 10 per cent of these products …See details»
Acylin Therapeutics - Crunchbase Company Profile & Funding
Founders Suresh Jain. Operating Status Active. Last Funding Type Series A. Company Type For Profit. Acylin Therapeutics is the first company focused on developing …See details»